CVE-2013-6309
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and...
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and consequently read records, modify records, or conduct transactions, via an unspecified link injection.
Exploit likelihood
What each source reports
NVD Score used
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and consequently read records, modify records, or conduct transactions, via an unspecified link injection.
- Record
CVE-2013-6309- CVSS 2.0
- 6.0 Medium
AV:N/AC:M/Au:S/C:P/I:P/A:P - Weakness
- CWE-94
- Updated
- 2026-11-02
CVE List No score
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and consequently read records, modify records, or conduct transactions, via an unspecified link injection.
- Record
CVE-2013-6309- Updated
- 2026-11-02
EUVDEUVD-2013-6135 No score
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and consequently read records, modify records, or conduct transactions, via an unspecified link injection.
- Record
EUVD-2013-6135- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-253c-crvf-xgfx No score
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and...
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and consequently read records, modify records, or conduct transactions, via an unspecified link injection.
- Record
GHSA-253c-crvf-xgfx- Weakness
- CWE-94
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2013-6309 is a medium vulnerability (CVSS 6.0) in Ibm Marketing Platform, published June 28, 2014. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.95%, the 61st percentile. No source names a fixed version.